I. Be aware of some of the research comparing cardiac CT with myocardial perfusion imaging.
|
- Diagnostic Performance of Coronary Angiography by 64-Row CT
Julie M. Miller, M.D., Carlos E. Rochitte, M.D., Marc Dewey, M.D., Armin Arbab-Zadeh, M.D., Hiroyuki Niinuma, M.D., Ph.D., Ilan Gottlieb, M.D., Narinder Paul, M.D., Melvin E. Clouse, M.D., Edward P. Shapiro, M.D., John Hoe, M.D., Albert C. Lardo, Ph.D., David E. Bush, M.D., Albert de Roos, M.D., Christopher Cox, Ph.D., Jeffery Brinker, M.D., and João A.C. Lima, M.D. N Engl J Med 2008; 359:2324-2336 November 27, 2008
|
- Coronary CT angiography versus standard evaluation in acute chest pain
N Engl J Med. 2012 Jul 26;367(4):299-308. doi: 10.1056/NEJMoa1201161. Hoffmann U1, Truong QA, Schoenfeld DA, Chou ET, Woodard PK, Nagurney JT, Pope JH, Hauser TH, White CS, Weiner SG, Kalanjian S, Mullins ME, Mikati I, Peacock WF, Zakroysky P, Hayden D, Goehler A, Lee H, Gazelle GS, Wiviott SD, Fleg JL, Udelson JE; ROMICAT-II Investigators.
|
|
|
|
- Coronary Computed Tomography Angiography for Early Triage of Patients With Acute Chest Pain: The ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) Trial
Hoffmann, Udo, Bamberg, Fabian, Chae, Claudia U., Nichols, John H., Rogers, Ian S., Seneviratne, Sujith K., Truong, Quynh A., Cury, Ricardo C., Abbara, Suhny, Shapiro, Michael D., Moloo, Jamaluddin, Butler, Javed, Ferencik, Maros, Lee, Hang, Jang, Ik-Kyung, Parry, Blair A., Brown, David F., Udelson, James E., Achenbach, Stephan, Brady, Thomas J., Nagurney, John T. J Am Coll Cardiol 2009 53: 1642-1650
|
J. Understand the controversies pertaining to cardiac CT particularly with regards to its costs and the costs of treating incidental findings.
|
|
|
|
K. Appreciate the role of late gadolinium MRI in risk stratifying patients with various forms of cardiomyopathy. Understand the additional prognostic information offered. |
- Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy
Assomull, Ravi G., Prasad, Sanjay K., Lyne, Jonathan, Smith, Gillian, Burman, Elizabeth D., Khan, Mohammed, Sheppard, Mary N., Poole-Wilson, Philip A., Pennell, Dudley J. J Am Coll Cardiol 2006 48: 1977-1985
|
|
|
L. Understand the seminal study involving survival analysis of patients with hypertrophic cardiomyopathy and scar as detected on late gadolinium MRI. |
- Toward clinical risk assessment inhypertrophic cardiomyopathy withgadolinium cardiovascular magnetic resonance
Moon, James C. C., McKenna, William J., McCrohon, Jane A., Elliott, Perry M., Smith, Gillian C., Pennell, Dudley J. J Am Coll Cardiol 2003 41: 1561-1567
|
- Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
Carolyn Y. Ho, M.D., Begoña López, Ph.D., Otavio R. Coelho-Filho, M.D., Neal K. Lakdawala, M.D., Allison L. Cirino, M.S., C.G.C., Petr Jarolim, M.D., Ph.D., Raymond Kwong, M.D., Arantxa González, Ph.D., Steven D. Colan, M.D., J.G. Seidman, Ph.D., Javier Díez, M.D., Ph.D., and Christine E. Seidman, M.D. N Engl J Med 2010; 363:552-563August 5, 2010
|
M. Appreciate how MRI guides the decision to revascularize and how this is superior to PET and myocardial perfusion imaging. |
- The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction
Raymond J. Kim, M.D., Edwin Wu, M.D., Allen Rafael, M.D., Enn-Ling Chen, Ph.D., Michele A. Parker, M.S., Orlando Simonetti, Ph.D., Francis J. Klocke, M.D., Robert O. Bonow, M.D., and Robert M. Judd, Ph.D. N Engl J Med 2000; 343:1445-1453November 16, 2000
|
|
|
N. Understand how MRI functions as a biomarker for iron involvement of the heart and how this has revolutionized survival of patients with thalassemia. |
|
- Cardiac T2* Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major
P. Kirk, M. Roughton, J.B. Porter, J.M. Walker, M.A. Tanner, J. Patel, D. Wu, J. Taylor, M.A. Westwood, L.J. Anderson, and D.J. Pennell Circulation. 2009;120:1961-1968, published online before print October 2 2009, doi:10.1161/CIRCULATIONAHA.109.874487
|
O. Understand how MRI helps with the decision who should get an ICD and who should receive cardiac resynchronization therapy. |
- Magnetic Resonance Assessment of the Substrate for Inducible Ventricular Tachycardia in Nonischemic Cardiomyopathy
Saman Nazarian, David A. Bluemke, Albert C. Lardo, Menekhem M. Zviman, Stanley P. Watkins, Timm L. Dickfeld, Glenn R. Meininger, Ariel Roguin, Hugh Calkins, Gordon F. Tomaselli, Robert G. Weiss, Ronald D. Berger, João A.C. Lima, and Henry R. Halperin Circulation. 2005;112:2821-2825, doi:10.1161/CIRCULATIONAHA.105.549659
|
- Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients With Left Ventricular Dysfunction
André Schmidt, Clerio F. Azevedo, Alan Cheng, Sandeep N. Gupta, David A. Bluemke, Thomas K. Foo, Gary Gerstenblith, Robert G. Weiss, Eduardo Marbán, Gordon F. Tomaselli, João A.C. Lima, and Katherine C. Wu Circulation. 2007;115:2006-2014, published online before print March 26 2007, doi:10.1161/CIRCULATIONAHA.106.653568
|
|
- Myocardial Fibrosis Predicts Appropriate Device Therapy in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death (Abstract)
Iles, Leah, Pfluger, Heinz, Lefkovits, Lisa, Butler, Michelle J., Kistler, Peter M., Kaye, David M., Taylor, Andrew J. J Am Coll Cardiol 2011 57: 821-828
|
P. Understand how CMR reduces sample size in clinical trial which use CMR parameters as end points, in comparison to echo |
|
|